World Cancer Day 2024: RemeGen Announces Three Significant Developments in the Global Fight Against Cancer, Narrowing the Care Gap

YANTAI, China, Feb. 2, 2024 /PRNewswire/ -- RemeGen Co. Ltd.("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, with

Related Keywords

China ,Thailand ,Shen Lin ,Henan ,Peking ,Beijing ,Yantai ,Shandong ,United States ,Remegen Disitamab Vedotin ,Disitamab Vedotin ,Innovent Biologics ,Jianmin Fang ,University Cancer Hospital ,Remegen Co ,Union For International Cancer Control ,Ltd Remegen ,Drug Administration For Center ,Scare Gap ,World Cancer Day ,State Food ,Drug Administration ,Drug Evaluation ,Professor Shen Lin ,Peking University Cancer Hospital ,Cancer Day ,International Cancer Control ,Thailand Business ,